AbL Diagnostics SA
PAR:ABLD

Watchlist Manager

AbL Diagnostics SA

PAR:ABLD

Watchlist

Dividends

Discount Rate

Price: 2.4 EUR -4% Market Closed

Market Cap: 38.7m EUR

Have any thoughts about
AbL Diagnostics SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 2.4 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ABLD Alert

AbL Diagnostics SA

2.4

-0.1 (-4%)

52 Week Range	2.4 9.7
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

AbL Diagnostics SA

What unique competitive advantages
does AbL Diagnostics SA hold over its rivals?

What risks and challenges
does AbL Diagnostics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of AbL Diagnostics SA.

What unique competitive advantages
does AbL Diagnostics SA hold over its rivals?

What risks and challenges
does AbL Diagnostics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AbL Diagnostics SA.

Provide P/S
for AbL Diagnostics SA.

Provide P/E
for AbL Diagnostics SA.

Provide P/OCF
for AbL Diagnostics SA.

Provide P/FCFE
for AbL Diagnostics SA.

Provide P/B
for AbL Diagnostics SA.

Provide EV/S
for AbL Diagnostics SA.

Provide EV/GP
for AbL Diagnostics SA.

Provide EV/EBITDA
for AbL Diagnostics SA.

Provide EV/EBIT
for AbL Diagnostics SA.

Provide EV/OCF
for AbL Diagnostics SA.

Provide EV/FCFF
for AbL Diagnostics SA.

Provide EV/IC
for AbL Diagnostics SA.

What are the Revenue projections
for AbL Diagnostics SA?

How accurate were the past Revenue estimates
for AbL Diagnostics SA?

What are the Net Income projections
for AbL Diagnostics SA?

How accurate were the past Net Income estimates
for AbL Diagnostics SA?

What are the EPS projections
for AbL Diagnostics SA?

How accurate were the past EPS estimates
for AbL Diagnostics SA?

What are the EBIT projections
for AbL Diagnostics SA?

How accurate were the past EBIT estimates
for AbL Diagnostics SA?

Compare the revenue forecasts
for AbL Diagnostics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AbL Diagnostics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AbL Diagnostics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of AbL Diagnostics SA compared to its peers.

Compare the P/E ratios
of AbL Diagnostics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing AbL Diagnostics SA with its peers.

Analyze the financial leverage
of AbL Diagnostics SA compared to its main competitors.

Show all profitability ratios
for AbL Diagnostics SA.

Provide ROE
for AbL Diagnostics SA.

Provide ROA
for AbL Diagnostics SA.

Provide ROIC
for AbL Diagnostics SA.

Provide ROCE
for AbL Diagnostics SA.

Provide Gross Margin
for AbL Diagnostics SA.

Provide Operating Margin
for AbL Diagnostics SA.

Provide Net Margin
for AbL Diagnostics SA.

Provide FCF Margin
for AbL Diagnostics SA.

Show all solvency ratios
for AbL Diagnostics SA.

Provide D/E Ratio
for AbL Diagnostics SA.

Provide D/A Ratio
for AbL Diagnostics SA.

Provide Interest Coverage Ratio
for AbL Diagnostics SA.

Provide Altman Z-Score Ratio
for AbL Diagnostics SA.

Provide Quick Ratio
for AbL Diagnostics SA.

Provide Current Ratio
for AbL Diagnostics SA.

Provide Cash Ratio
for AbL Diagnostics SA.

What is the historical Revenue growth
over the last 5 years for AbL Diagnostics SA?

What is the historical Net Income growth
over the last 5 years for AbL Diagnostics SA?

What is the current Free Cash Flow
of AbL Diagnostics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for AbL Diagnostics SA.

EV/EBITDA
Enterprise Value to EBITDA

-59

Current

-69.8

Median

8.9

Industry

Higher than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-59

Enterprise Value

38.7m EUR

EBITDA

-657.1k EUR

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
FR		AbL Diagnostics SA PAR:ABLD	38.7m EUR	-59
JP		Itochu Corp TSE:8001	10.9T JPY	11.4
JP		Mitsubishi Corp TSE:8058	10T JPY	11.4
JP		Mitsui & Co Ltd TSE:8031	9.5T JPY	13.6
US	W	WW Grainger Inc XMUN:GWW	51.1B EUR	19.4
US		W W Grainger Inc NYSE:GWW	52.7B USD	19.2
US		United Rentals Inc NYSE:URI	47.1B USD	8.5
US		Fastenal Co NASDAQ:FAST	42.6B USD	25.1
UK	F	Ferguson PLC NYSE:FERG	35.2B USD	13
IN		Adani Enterprises Ltd NSE:ADANIENT	2.7T INR	23.2
UK		Ashtead Group PLC LSE:AHT	21.6B GBP	192

				EBITDA Growth	EV/EBITDA to Growth
FR		AbL Diagnostics SA PAR:ABLD	Average EV/EBITDA: 33.7 Negative Multiple: -59	N/A	N/A
JP		Itochu Corp TSE:8001	11.4	15%	0.8
JP		Mitsubishi Corp TSE:8058	11.4	0%	N/A
JP		Mitsui & Co Ltd TSE:8031	13.6	17%	0.8
US	W	WW Grainger Inc XMUN:GWW	19.4	22%	0.9
US		W W Grainger Inc NYSE:GWW	19.2	22%	0.9
US		United Rentals Inc NYSE:URI	8.5	19%	0.4
US		Fastenal Co NASDAQ:FAST	25.1	19%	1.3
UK	F	Ferguson PLC NYSE:FERG	13	25%	0.5
IN		Adani Enterprises Ltd NSE:ADANIENT	23.2	116%	0.2
UK		Ashtead Group PLC LSE:AHT	192	11%	16.9

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

38.3

2-Years Forward

EV/EBITDA

18.7

3-Years Forward

EV/EBITDA

14.6

	Franklin Covey Co NYSE:FC	36.285 USD -0.34%
	Mohawk Industries Inc NYSE:MHK	118.94 USD -0.18%
	Ardmore Shipping Corp NYSE:ASC	11.75 USD 3.89%
	ASGN Inc NYSE:ASGN	83.15 USD -0.86%
	Skyworks Solutions Inc NASDAQ:SWKS	89.83 USD 1.22%
	Weatherford International PLC NASDAQ:WFRD	68.3 USD 1.79%

	Johnson & Johnson NYSE:JNJ	144.46 USD -0.01%
	Bank of America Corp NYSE:BAC	43.64 USD -1.2%
	Mastercard Inc NYSE:MA	526.595 USD -0.28%
	Salesforce Inc NYSE:CRM	342.5 USD -0.33%
	Abbvie Inc NYSE:ABBV	177.35 USD 1.01%
	Home Depot Inc NYSE:HD	391.34 USD -0.32%

	Arista Networks Inc NYSE:ANET	113.2299 USD 0.37%
	Visa Inc NYSE:V	316.345 USD -0.43%
	Texas Pacific Land Corp NYSE:TPL	1 128.33 USD -0.42%
	KLA Corp NASDAQ:KLAC	647.28 USD 2.85%
	Manhattan Associates Inc NASDAQ:MANH	276.82 USD -1.23%
	Pinduoduo Inc NASDAQ:PDD	99.865 USD 0.36%

	Salesforce Inc NYSE:CRM	342.5 USD -0.33%
	Accenture PLC NYSE:ACN	358.77 USD -2.07%
	ServiceNow Inc NYSE:NOW	1 088 USD -0.3%
	EOG Resources Inc NYSE:EOG	119.73 USD 0.58%
	Copart Inc NASDAQ:CPRT	58.27 USD 0.09%
	Applied Materials Inc NASDAQ:AMAT	167.15 USD 2.18%

AbL Diagnostics SA
PAR:ABLD

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

AbL Diagnostics SA PAR:ABLD

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

AbL Diagnostics SA
PAR:ABLD

EV/EBITDA
Enterprise Value to EBITDA